Articles

Linear Capital Portfolio Company | Boyi Huixin Secures China's First NMPA Class III Approval for Vascular Interventional Surgery Planning Software!

Linear Capital Portfolio Company | Boyi Huixin Secures China's First NMPA Class III Approval for Vascular Interventional Surgery Planning Software!

On November 1, 2023, DetecMicro®, a vascular interventional surgical planning software independently developed by Boyi Huixin (Hangzhou) Network Technology Co., Ltd. ("Boyi Huixin"), a portfolio company of Linear Capital, officially received Class III medical device registration approval (National Medical Device Registration Certificate No. 20233211596) from the National Medical Products Administration (NMPA). DetecMicro